The NAFLD-MAFLD debate: Eminence vs evidence
- PMID: 33220154
- DOI: 10.1111/liv.14739
The NAFLD-MAFLD debate: Eminence vs evidence
Abstract
Debates are inevitable in science and could be a powerful tool for addressing controversial topics as it promotes critical thinking and inspires individuals to consider alternate viewpoints. However, debates can help only to identify the issues that need to be clarified to address this question, but it can never help resolve the controversy itself. In the era of evidence-based medicine, the need for an evidence-based debate is mandatory. Polarising opinions and major debate have recently arisen in hepatology on the nomenclature and diagnostic criteria for fatty liver disease associated with metabolic dysfunction (non alcoholic fatty liver disease [NAFLD]-metabolic (dysfunction) associated fatty liver disease [MAFLD] debate). The aim of this viewpoint is to suggest a way to settle the debate through evidence. Descriptive review using PubMed to identify literature on the evidence and eminence-based medicine and studies comparing MAFLD and NAFLD criteria. The emerging studies comparing the performance of diagnostic criteria of NAFLD and MAFLD represent the dawn of a new era for reframing the ongoing debate by acquisition of the mandatory evidence that will both resolve the debate and lead to novel avenues of research. In conclusion, the time has come to hold debate and focus on gathering and building the evidence to settle it. It does not matter who wins the debate and once there is robust evidence, we should all follow it wherever it leads.
Keywords: MAFLD; NAFLD; debate; evidence..
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Comment in
-
Re: Fouad Y, et al. The NAFLD-MAFLD debate: Eminence versus evidence. Liver Int. 2020 Nov 21. doi: 10.1111/liv.14739.Liver Int. 2021 May;41(5):1162-1163. doi: 10.1111/liv.14750. Epub 2021 Jan 2. Liver Int. 2021. PMID: 33280222 No abstract available.
Similar articles
-
The NAFLD-MAFLD debate: Is there a Consensus-on-Consensus methodology?Liver Int. 2022 Apr;42(4):742-748. doi: 10.1111/liv.15197. Epub 2022 Feb 24. Liver Int. 2022. PMID: 35182007 Review.
-
Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction-associated fatty liver disease.J Gastroenterol Hepatol. 2022 May;37(5):795-811. doi: 10.1111/jgh.15787. Epub 2022 Feb 8. J Gastroenterol Hepatol. 2022. PMID: 35080048 Free PMC article. Review.
-
Why MASLD Lags Behind MAFLD: A Critical Analysis of Diagnostic Criteria Evolution in Metabolic Dysfunction-Associated Liver Diseases.Med Sci Monit. 2024 Jul 30;30:e945198. doi: 10.12659/MSM.945198. Med Sci Monit. 2024. PMID: 39075772 Free PMC article. Review.
-
Muscle strength and non-alcoholic fatty liver disease/metabolic-associated fatty liver disease.World J Gastroenterol. 2024 Feb 21;30(7):636-643. doi: 10.3748/wjg.v30.i7.636. World J Gastroenterol. 2024. PMID: 38515958 Free PMC article.
-
Metabolic-associated fatty liver disease (MAFLD) in coeliac disease.Liver Int. 2021 Apr;41(4):788-798. doi: 10.1111/liv.14767. Epub 2020 Dec 28. Liver Int. 2021. PMID: 33319459
Cited by
-
Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention.Cardiovasc Diabetol. 2022 Dec 3;21(1):270. doi: 10.1186/s12933-022-01697-0. Cardiovasc Diabetol. 2022. PMID: 36463192 Free PMC article. Review.
-
Nonalcoholic fatty liver disease in inflammatory arthritis: Relationship with cardiovascular risk.Front Immunol. 2022 Sep 23;13:997270. doi: 10.3389/fimmu.2022.997270. eCollection 2022. Front Immunol. 2022. PMID: 36211332 Free PMC article. Review.
-
An international multidisciplinary consensus statement on MAFLD and the risk of CVD.Hepatol Int. 2023 Aug;17(4):773-791. doi: 10.1007/s12072-023-10543-8. Epub 2023 May 19. Hepatol Int. 2023. PMID: 37204656 Free PMC article.
-
Do MAFLD Patients with Harmful Alcohol Consumption Have a Different Dietary Intake?Nutrients. 2022 Mar 23;14(7):1335. doi: 10.3390/nu14071335. Nutrients. 2022. PMID: 35405948 Free PMC article.
-
Bioengineering liver microtissues for modeling non-alcoholic fatty liver disease.EXCLI J. 2023 Mar 20;22:367-391. doi: 10.17179/excli2022-5892. eCollection 2023. EXCLI J. 2023. PMID: 37223084 Free PMC article. Review.
References
REFERENCES
-
- Lin S-J, Crawford SY. An online debate series for first-year pharmacy students. Am J Pharm Edu. 2007;71:12.
-
- Garrett M, Schoener L, Hood L. Debate: A teaching strategy to improve verbal communication and critical-thinking skills. Nurse Educ. 1996;21:37-40.
-
- Nguyen VQC, Hirsch MA. Use of a policy debate to teach residents about health care reform. J Grad Med Educ. 2011;3:376-378.
-
- Khan SA, Omar H, Babar MG, Toh CG. Utilization of debate as an educational tool to learn health economics for dental students in Malaysia. J Dent Educ. 2012;76:1675-1683.
-
- Koklanaris N, MacKenzie AP, Fino ME, Arslan AA, Seubert DE. Debate preparation/participation: an active, effective learning tool. Teach Learn Med. 2008;20:235-238.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical